DNLI Shares Outstanding History



Below is a table of the DNLI shares outstanding history going back to 12/8/2017:

Date DNLI Shares Outstanding
12/8/201782.42M
3/12/201894.43M
5/4/201894.44M
8/2/201894.81M
11/2/201894.96M
3/5/201995.29M
5/1/201995.48M
7/31/201995.84M
10/30/201996.03M
2/19/2020105.42M
4/29/2020105.63M
8/3/2020105.98M
10/28/2020119.92M
2/17/2021120.98M
4/26/2021121.19M
7/28/2021121.64M
10/29/2021122.13M
2/18/2022122.83M
4/28/2022122.95M
8/1/2022123.35M
10/27/2022135.81M
2/21/2023136.68M
5/1/2023136.89M
7/31/2023137.42M
10/30/2023138.20M
2/20/2024139.16M
4/30/2024142.61M
7/25/2024143.17M
10/30/202426.05M

Also see: DNLI Market Cap History
DNLI YTD Return
DNLI Historical Shares Outstanding:
-15.38% CAGR
DNLI Historical Shares Outstanding: +-15.38% CAGR

Mouse over chart for data details
12/8/2017 ...10/30/2024
Denali Therapeutics Inc. is a biopharmaceutical company. Co. is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. Co. has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson's disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). We show 29 historical shares outstanding datapoints in our coverage of DNLI's shares outstanding history.

Understanding the changing numbers of DNLI shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DNLI versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DNLI by allowing them to research DNLI shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree DNLI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Denali Therapeutics (DNLI) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

DNTH Shares Outstanding History
DOMH Shares Outstanding History
DOVA Shares Outstanding History
DPLO Shares Outstanding History
DRAD Shares Outstanding History
DRIO Shares Outstanding History
DRMA Shares Outstanding History
DRNA Shares Outstanding History
DRRX Shares Outstanding History
DSGN Shares Outstanding History
More Healthcare companies »

 

DNLI Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2025, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.